|Bid||14.200 x 400000|
|Ask||14.300 x 400000|
|Day's Range||13.790 - 14.380|
|52 Week Range||11.442 - 22.700|
|PE Ratio (TTM)||89.34|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Celgene Corporation (NASDAQ: CELG ) — which is recently very much in the news, although for dubious reasons — has struck a partnership with Germany's Evotec AG (ADR) (OTC: EVTCY ), which partners with ...
After looking at Evotec AG’s (XTRA:EVT) latest earnings announcement (31 December 2017), I found it useful to revisit the company’s performance in the past couple of years and assess thisRead More...
The latest earnings announcement Evotec AG’s (XTRA:EVT) released in December 2017 confirmed that the business endured a immense headwind with earnings declining by -11.89%. Below is a brief commentary onRead More...
Evotec AG (XTRA:EVT), a life sciences company based in Germany, saw a significant share price rise of over 20% in the past couple of months on the XTRA. With manyRead More...
Evotec AG’s (XTRA:EVT) most recent return on equity was a substandard 8.96% relative to its industry performance of 9.32% over the past year. EVT’s results could indicate a relatively inefficientRead More...